时间依赖的蛋白质组学和药物反应在扩大癌细胞中的作用
Yuting Pan1, Ying Xuan1, Piliang Hao2
1Center for Chemical Biology, Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, PR China.
Pharmacological research
|May 10, 2024
概括
癌细胞随着时间的推移而变化,影响药物的有效性. 研究人员发现了新的天然化合物,向这些不断增长的癌细胞,改善了癌症治疗的药物发现.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 癌细胞系是抗癌药物开发的标准模型.
- 由于稳定的细胞遗传学和蛋白质组学,药物反应通常被认为是恒定的.
研究的目的:
- 为了研究扩张过程中癌细胞蛋白质组的动态变化.
- 评估这些变化对抗癌药物疗效的影响.
- 确定针对长期生长的癌细胞的新型治疗剂.
主要方法:
- 在达到结合点后监测癌细胞分裂和蛋白质组学.
- 评估FDA批准的药物库对扩大癌细胞的抑制作用.
- 选天然产品,以选择性抑制过度生长的癌细胞.
主要成果:
- 癌细胞在扩张过程中表现出连续的蛋白质组重编程,与细胞分裂,粘附和新陈代谢有关.
- 大多数抗癌药物在扩大细胞培养的有效性降低,特别是在第三天.
- 线粒体抑制剂TAK165是这种反应减弱的例外.
- 四种五环三烯被确定为癌细胞过度生长的选择性抑制剂.
结论:
- 在体外扩张过程中,癌细胞的行为和药物反应是动态的,而不是静态的.
- 标准药物评估方法可能会高估疗效,原因是未解决的细胞扩张.
- 需要针对过度生长的癌细胞的新型治疗策略,确定了有希望的天然产品.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
Diversity in Cell Signaling Responses
6.4K
The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity.
Graded and Abrupt Responses
Some signaling systems generate...
Graded and Abrupt Responses
Some signaling systems generate...
6.4K
Chronopharmacokinetics: Time-Dependent Pharmacokinetics
126
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
126


